Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 13 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 11013803

    Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 25, 2021 · Expires May 20, 2041

    granted

  2. US 11013767

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted May 25, 2021 · Expires May 20, 2041

    granted

  3. US 11013704

    Compounds supports hematopoietic stem cells and red blood cells

    The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

    granted

  4. US 11006626

    Compounds for protection of cells

    Sulfateq B.V. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  5. US 11008548

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Precision BioSciences, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  6. US 10994014

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted May 4, 2021 · Expires Apr 29, 2041

    granted

  7. US 10993959

    Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)

    Regents of the University of Minnesota · Granted May 4, 2021 · Expires Apr 29, 2041

    granted

  8. US 10993419

    Genetically modified cells, tissues, and organs for treating disease

    Regents of the University of Minnesota · Granted May 4, 2021 · Expires Apr 29, 2041

    granted

  9. US 10995317

    NK cells exhibiting an adaptive phenotype and methods for preparing and for using

    Regents of the University of Minnesota · Granted May 4, 2021 · Expires Apr 29, 2041

    granted

  10. US 10988733

    Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue

    China Medical University · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  11. US 10988734

    Methods for preparing therapeutically active cells using microfluidics

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  12. US 10973894

    Methods of isolating T cells having antigenic specificity for a cancer-specific mutation

    The United States of America, as represented by the Secretary, Department of Health and Human · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  13. US 10975355

    Controlled induction of human pancreatic progenitors produces functional beta-like cells

    The Regents of the University of California · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  14. US 10954529

    Minimal volume reprogramming of mononuclear cells

    Fate Therapeutics, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  15. US 10946080

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  16. US 10934527

    Generation of lineage-restricted progenitor cells from differentiated cells

    The Regents of the University of California · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  17. US 10927346

    Enhanced immune effector cells and use thereof

    Fate Therapeutics, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  18. US 10927160

    Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof

    The Regents of the University of California · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  19. US 10927182

    Humanized BCMA antibody and BCMA-CAR-T cells

    Caribou Biosciences, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  20. US 10925902

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  21. US 10905782

    Compositions for enhancing transport of molecules into cells

    Sarepta Therapeutics, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  22. US 10894065

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  23. US 10894061

    Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells

    Regents of the University of Minnesota · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  24. US 10888589

    Modulation of stem cells using zinc finger proteins

    Sangamo Therapeutics, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.